TY  - JOUR
AU  - Palomo, Marta
AU  - Blasco, Miquel
AU  - Molina, Patricia
AU  - Lozano, Miquel
AU  - Praga, Manuel
AU  - Torramade-Moix, Sergi
AU  - Martinez-Sanchez, Julia
AU  - Cid, Joan
AU  - Escolar, Gines
AU  - Carreras, Enric
AU  - Paules, Cristina
AU  - Crispi, Fatima
AU  - Quintana, Luis F
AU  - Poch, Esteban
AU  - Rodas, Lida
AU  - Goma, Emma
AU  - Morelle, Johann
AU  - Espinosa, Mario
AU  - Morales, Enrique
AU  - Avila, Ana
AU  - Cabello, Virginia
AU  - Ariceta, Gema
AU  - Chocron, Sara
AU  - Manrique, Joaquin
AU  - Barros, Xoana
AU  - Martin, Nadia
AU  - Huerta, Ana
AU  - Fraga-Rodriguez, Gloria M
AU  - Cao, Mercedes
AU  - Martin, Marisa
AU  - Romera, Ana Maria
AU  - Moreso, Francesc
AU  - Manonelles, Anna
AU  - Gratacos, Eduard
AU  - Pereira, Arturo
AU  - Campistol, Josep M
AU  - Diaz-Ricart, Maribel
PY  - 2019
DO  - 10.2215/CJN.05830519
UR  - http://hdl.handle.net/10668/14648
T2  - Clinical journal of the American Society of Nephrology : CJASN
AB  - Atypical hemolytic uremic syndrome is a form of thrombotic microangiopathy caused by dysregulation of the alternative complement pathway. There is evidence showing complement activation in other thrombotic microangiopathies. The aim of this study was...
LA  - en
KW  - HELLP syndrome
KW  - alternative
KW  - antibodies
KW  - atypical hemolytic uremic syndrome
KW  - complement C9
KW  - complement activation
KW  - complement membrane
KW  - complement pathway
KW  - complement system proteins
KW  - eculizumab
KW  - endothelial cells
KW  - female
KW  - fibrin
KW  - fluorescent antibody technique
KW  - humanized
KW  - humans
KW  - hypertension
KW  - malignant
KW  - monoclonal
KW  - pre-eclampsia
KW  - pregnancy
KW  - recurrence
KW  - thrombotic microangiopathies
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - Atypical Hemolytic Uremic Syndrome
KW  - Complement Activation
KW  - Complement Membrane Attack Complex
KW  - Female
KW  - HELLP Syndrome
KW  - Humans
KW  - Male
KW  - Pre-Eclampsia
KW  - Pregnancy
KW  - Thrombotic Microangiopathies
TI  - Complement Activation and Thrombotic Microangiopathies.
TY  - research article
VL  - 14
ER  -